Cardiovascular implications of inflammatory bowel disease: An updated review

Arshia Bhardwaj1, Arshdeep Singh1, Vandana Midha2

  • 1Department of Gastroenterology, Dayanand Medical College and Hospital, Punjab, Ludhiana 141001, India.

PubMed

Insights

Patients with inflammatory bowel disease (IBD) face increased risks of atherosclerotic cardiovascular diseases (ASCVD). This review examines IBD-ASCVD links, mechanisms, and treatment impacts on heart health.

Area of Science:

  • Gastroenterology
  • Cardiology
  • Rheumatology

Background:

  • Chronic inflammatory disorders, like inflammatory bowel disease (IBD), are increasingly linked to higher risks of atherosclerotic cardiovascular diseases (ASCVD).
  • Understanding this association is crucial for managing patient health comprehensively.

Purpose of the Study:

  • To review epidemiological data connecting IBD and ASCVD.
  • To elucidate potential underlying mechanisms driving this association.
  • To evaluate the cardiovascular risks associated with IBD treatments, including novel small molecule drugs.

Main Methods:

  • Comprehensive literature search of PubMed (inception to August 2023).
  • Keywords included IBD (Crohn's disease, ulcerative colitis) and ASCVD (coronary artery disease, heart failure, atrial fibrillation, etc.).
  • Inclusion of diverse study types: cohort studies, clinical trials, meta-analyses, and guidelines.

Main Results:

  • Emerging data confirms a heightened ASCVD risk in IBD patients.
  • Potential mechanisms linking IBD and ASCVD are explored.
  • Cardiovascular effects of IBD therapies, including small molecule drugs, are analyzed, with comparisons to rheumatoid arthritis.

Conclusions:

  • There is a significant intersection between inflammatory bowel disease and cardiovascular health.
  • Further research and clinical attention are warranted to mitigate ASCVD risk in IBD patients.
  • Evaluation of cardiovascular safety profiles for IBD treatments is essential.

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...